title: [Treatment strategy for myeloproliferative neoplasms].
authors.forename: Goichi
authors.initials: G
authors.lastname: Yoshimoto
authors.forename: Toshihiro
authors.initials: T
authors.lastname: Miyamoto
mesh_terms: D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D001241:Aspirin / Q000008:administration & dosage; D037282:Calreticulin / Q000235:genetics; D002219:Carbamates / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D006918:Hydroxyurea / Q000008:administration & dosage; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D053614:Janus Kinase 2 / Q000235:genetics; D058990:Molecular Targeted Therapy; D009154:Mutation; D009570:Nitriles; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage; D011087:Polycythemia Vera / Q000175:diagnosis / Q000235:genetics / Q000628:therapy*; D055728:Primary Myelofibrosis / Q000175:diagnosis / Q000235:genetics / Q000628:therapy*; D011379:Prognosis; D011720:Pyrazoles / Q000008:administration & dosage; D011743:Pyrimidines; D011799:Quinazolines / Q000008:administration & dosage; D053628:Receptors, Thrombopoietin / Q000235:genetics; D013792:Thalidomide / Q000008:administration & dosage; D013920:Thrombocythemia, Essential / Q000175:diagnosis / Q000235:genetics / Q000628:therapy*
chemical_list: D000305:Adrenal Cortex Hormones; D037282:Calreticulin; D002219:Carbamates; D007166:Immunosuppressive Agents; D009570:Nitriles; D010975:Platelet Aggregation Inhibitors; D011720:Pyrazoles; D011743:Pyrimidines; D011799:Quinazolines; D053628:Receptors, Thrombopoietin; C082218:MPL protein, human; D013792:Thalidomide; C575255:givinostat; C540383:ruxolitinib; C507924:JAK2 protein, human; D053614:Janus Kinase 2; C021139:anagrelide; D001241:Aspirin; D006918:Hydroxyurea